GuidanceMHRA
Early Access to Medicines Scheme: Overview
The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions early access to medicines that show early signs of having a major advantage over existing therapeutics.
First published: Sep 9, 2024Last updated: Mar 2, 2026Changes: 7
Latest change: Updated EAMS Submission dates to run until 2028
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.